Aardvark Therapeutics Inc (AARD)

EBITDA Growth

-0.14%

Quarterly · Period ending:

AARD logo

AARD EBITDA Growth

Year-over-year change vs the same period a year earlier

Latest reported-0.14%
AARD Quarterly EBITDA YoY % (-182.79% → -0.14%)
High-resolution chart · PNG

AARD ebitda growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Aardvark Therapeutics Inc EBITDA Growth — Quarterly
Period endingEBITDA Growth
-0.1393%
-131.8861%
-100.3417%
-290.6564%
-138.8288%
-327.6195%
-330.9769%
-182.7913%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.